Brendan Weiss, MD, offers an overview of treatment and prognostic considerations for the monoclonal protein-related diseases with a focus on monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma and AL amyloidosis.
Related Links
- Restoration of Immunity in Lymphopenic Patients with Cancer via Immunotherapy with Vaccination and Adoptive T cell Transfer
- Case Study: A 51-year-old man with a lytic rib lesion, spinal compression fracture, monoclonal IgA antibodies, and 46% plasma cells in his bone marrow diagnosed with multiple myeloma
- Dr Weiss’ Profile
Published
August 14, 2014
Created by
BROADCASTMED